Latest Breaking News On - Jacka khattar - Page 1 : comparemela.com

Supernus Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference

Supernus Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesTimothyc decPeter vozzoJacka khattarJack khattarSupernus pharmaceuticalsExchange commissionMarriott marquis hotelSecurities exchangeSupernus pharmaceuticals incJefferies global healthcare conferenceInvestor relationsPrivate securities litigation reform actSecurities exchange actSenior vice president

Supernus Pharmaceuticals to Participate in the Jefferies

Supernus Pharmaceuticals to Participate in the Jefferies
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesTimothyc decJacka khattarPeter vozzoJack khattarSecurities exchangeSupernus pharmaceuticals incMarriott marquis hotelExchange commissionSupernus pharmaceuticalsJefferies global healthcare conferenceInvestor relationsPrivate securities litigation reform actSecurities exchange actSenior vice president

Supernus Announces Promising Interim Data from Ongoing Open-Label Phase 2a Study of SPN-817 in Epilepsy

Supernus Announces Promising Interim Data from Ongoing Open-Label Phase 2a Study of SPN-817 in Epilepsy
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Timothyc decPeter vozzoJack khattarJacka khattarDrug administrationSupernus pharmaceuticals incSupernus pharmaceuticalsExchange commissionCompany investor relationsSecurities exchangeAnnounces promising interim dataOngoing open label phaseInvestor relationsOrphan drugDravet syndromeLennox gastaut syndrome

Supernus Pharmaceuticals to Host Webcast to Review Interim Data from Ongoing Open-Label Phase IIa Study of SPN-817 for Treatment-Resistant Seizures

Supernus Pharmaceuticals to Host Webcast to Review Interim Data from Ongoing Open-Label Phase IIa Study of SPN-817 for Treatment-Resistant Seizures
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Timothyc decPeter vozzoJacka khattarExchange commissionSupernus pharmaceuticalsCompany investor relationsSupernus pharmaceuticals incSecurities exchangeHost webcastReview interim dataOngoing open label phaseInvestor relationsPrivate securities litigation reform actSecurities exchange actSenior vice president

Supernus Pharmaceuticals : 2023 Annual Report

Dear Supernus Stockholder, We are very pleased with our performance in 2023 as we continued to successfully transition from our mature brands and set the stage to.

United statesJacka khattarStock marketShire laboratories incTakeda pharmaceutical company ltdSupernus pharmaceuticalsSupernus pharmaceuticals incAdamas operationsMdd us operationsDrug administrationSecurities exchangeExchange commissionShire plcStock exchangeDear supernus stockholderNovel non stimulant